These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16356671)

  • 21. Applicator and electrode design for in vivo DNA delivery by electroporation.
    Rabussay D
    Methods Mol Biol; 2008; 423():35-59. PubMed ID: 18370189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug and gene delivery using electrotransfer].
    Préat V
    Ann Pharm Fr; 2001 Jul; 59(4):239-44. PubMed ID: 11468578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA.
    Inoue T; Sugimoto M; Sakurai T; Saito R; Futaki N; Hashimoto Y; Honma Y; Arai I; Nakaike S
    J Gene Med; 2007 Nov; 9(11):994-1001. PubMed ID: 17703497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction and optimization of gene transfection and drug delivery by electroporation.
    Canatella PJ; Prausnitz MR
    Gene Ther; 2001 Oct; 8(19):1464-9. PubMed ID: 11593359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical safety assessment of a DNA vaccine using particle-mediated epidermal delivery in domestic pig, minipig and mouse.
    Dincer Z; Jones S; Haworth R
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):351-7. PubMed ID: 16713213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoelectroporation: a first look.
    Sundararajan R
    Methods Mol Biol; 2008; 423():109-28. PubMed ID: 18370193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electroporation-mediated intradermal delivery of DNA vaccines in nonhuman primates.
    Adam L; Le Grand R; Martinon F
    Methods Mol Biol; 2014; 1121():309-13. PubMed ID: 24510834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electroporation at low voltages enables DNA vaccine to provide protection against a lethal H5N1 avian influenza virus challenge in mice.
    Zhou Y; Fang F; Chen J; Wang H; Chang H; Yang Z; Chen Z
    Intervirology; 2008; 51(4):241-6. PubMed ID: 18812697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months.
    Tsang C; Babiuk S; van Drunen Littel-van den Hurk S; Babiuk LA; Griebel P
    Vaccine; 2007 Jul; 25(30):5485-94. PubMed ID: 17408815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research.
    Gehl J
    Acta Physiol Scand; 2003 Apr; 177(4):437-47. PubMed ID: 12648161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
    Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
    J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation.
    Cristillo AD; Weiss D; Hudacik L; Restrepo S; Galmin L; Suschak J; Draghia-Akli R; Markham P; Pal R
    Biochem Biophys Res Commun; 2008 Feb; 366(1):29-35. PubMed ID: 18036339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for DNA vaccine delivery.
    Alpar HO; Papanicolaou I; Bramwell VW
    Expert Opin Drug Deliv; 2005 Sep; 2(5):829-42. PubMed ID: 16296781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective delivery of DNA into tumor cells and tissues by electroporation of polymer-DNA complex.
    Kang JH; Toita R; Niidome T; Katayama Y
    Cancer Lett; 2008 Jul; 265(2):281-8. PubMed ID: 18375054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delivery of noncarrier naked DNA vaccine into the skin by supersonic flow induces a polarized T helper type 1 immune response to cancer.
    Lin CC; Yen MC; Lin CM; Huang SS; Yang HJ; Chow NH; Lai MD
    J Gene Med; 2008 Jun; 10(6):679-89. PubMed ID: 18324638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of menstrual cycle on gene transfection through mouse vagina for DNA vaccine.
    Kanazawa T; Takashima Y; Hirayama S; Okada H
    Int J Pharm; 2008 Aug; 360(1-2):164-70. PubMed ID: 18573624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change of biophysical properties of the skin caused by ultraviolet radiation-induced photodamage in Koreans.
    Lim SH; Kim SM; Lee YW; Ahn KJ; Choe YB
    Skin Res Technol; 2008 Feb; 14(1):93-102. PubMed ID: 18211607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
    Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K
    Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.